Drugs / Hair Stimulating Complex
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03662854 | Jul 2018 → Jan 2019 | alopecia | Histogen | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01501617 | Dec 2011 → Jun 2012 | androgenetic alopecia | Histogen | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hair Stimulating Complex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03662854 ↗ |
| Known as | HSC | “Hair Stimulating Complex (HSC) is derivative of hypoxia-induced multipotent cell conditioned media enriched for certain key growth factors” NCT03662854 ↗1“Hair Stimulating Complex (HSC)” NCT01501617 ↗ |
| Modality | Protein / enzyme biologic | “HSC consists of proteins secreted by human dermal cells” NCT01501617 ↗ |